Immunochemical detection of cytochrome P450 enzymes in small intestine microsomes of male and female untreated juvenile cynomolgus monkeys

References

• Guengerich FP. (2003). Cytochromes P450, drugs, and diseases. Mol Interv 3:194–204
   PubMedGoogle Scholar
• Hashizume T, Imaoka S, Mise M, et al. (2002). Involvement of CYP2J2 and CYP4F12 in the metabolism of ebastine in human intestinal microsomes. J Pharmacol Exp Ther 300:298–304
   PubMed Web of Science ®Google Scholar
• Iwasaki K, Murayama N, Koizumi R, et al. (2010). Comparison of cytochrome P450 3A enzymes in cynomolgus monkeys and humans. Drug Metab Pharmacokinet 25:388–91
   PubMed Web of Science ®Google Scholar
• King LM, Ma J, Srettabunjong S, et al. (2002). Cloning of CYP2J2 gene and identification of functional polymorphisms. Mol Pharmacol 61:840–52
   PubMed Web of Science ®Google Scholar
• Lee CA, Neul D, Clouser-Roche A, et al. (2010). Identification of novel substrates for human cytochrome P450 2J2. Drug Metab Dispos 38:347–56
   PubMed Web of Science ®Google Scholar
• Matsumoto S, Hirama T, Matsubara T, et al. (2002). Involvement of CYP2J2 on the intestinal first-pass metabolism of antihistamine drug, astemizole. Drug Metab Dispos 30:1240–5
   PubMed Web of Science ®Google Scholar
• Nakanishi Y, Matsushita A, Matsuno K, et al. (2010). Regional distribution of cytochrome P450 mRNA expression in the liver and small intestine of cynomolgus monkeys. Drug Metab Pharmacokinet 25:290–7
   PubMed Web of Science ®Google Scholar
• Nakanishi Y, Matsushita A, Matsuno K, et al. (2011). Regional distribution of drug-metabolizing enzyme activities in the liver and small intestine of cynomolgus monkey. Drug Metab Pharmacokinet 26:288–94
   PubMed Web of Science ®Google Scholar
• Nakanishi Y, Yamashita H, Yoshikawa T, et al. (2013). Cytochrome P450 metabolic activities in the small intestine of cynomolgus macaques bred in Cambodia, China, and Indonesia. Drug Metab Pharmacokinet 28:510--13
   Google Scholar
• Nelson DR, Zeldin DC, Hoffman SM, et al. (2004). Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants. Pharmacogenetics 14:1–18
   PubMedGoogle Scholar
• Nishimuta H, Sato K, Mizuki Y, et al. (2011). Species differences in intestinal metabolic activities of cytochrome P450 isoforms between cynomolgus monkeys and humans. Drug Metab Pharmacokinet 26:300–6
   PubMed Web of Science ®Google Scholar
• Ogasawara A, Utoh M, Nii K, et al. (2009). Effect of oral ketoconazole on oral and intravenous pharmacokinetics of simvastatin and its acid in cynomolgus monkeys. Drug Metab Dispos 37:122–8
   PubMed Web of Science ®Google Scholar
• Omura T, Sato R. (1964). The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. J Biol Chem 239:2370–8
   PubMed Web of Science ®Google Scholar
• Paine MF, Hart HL, Ludington SS, et al. (2006). The human intestinal cytochrome P450 “pie”. Drug Metab Dispos 34:880–6
   PubMed Web of Science ®Google Scholar
• Paine MF, Schmiedlin-Ren P, Watkins PB. (1999). Cytochrome P-450 1A1 expression in human small bowel: interindividual variation and inhibition by ketoconazole. Drug Metab Dispos 27:360–4
   PubMed Web of Science ®Google Scholar
• Paine MF, Shen DD, Kunze KL, et al. (1996). First-pass metabolism of midazolam by the human intestine. Clin Pharmacol Ther 60:14–24
   PubMed Web of Science ®Google Scholar
• Shimada T, Yamazaki H, Mimura M, et al. (1994). Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther 270:414–23
   PubMed Web of Science ®Google Scholar
• Takahashi M, Washio T, Suzuki N, et al. (2008). Characterization of gastrointestinal drug absorption in cynomolgus monkeys. Mol Pharm 5:340–8
   PubMedGoogle Scholar
• Uehara S, Murayama N, Nakanishi Y, et al. (2011). Immunochemical detection of cytochrome P450 enzymes in liver microsomes of 27 cynomolgus monkeys. J Pharmacol Exp Ther 339:654–61
   PubMed Web of Science ®Google Scholar
• Uehara S, Murayama N, Yamazaki H, Uno Y. (2010). A novel CYP2A26 identified in cynomolgus monkey liver metabolizes coumarin. Xenobiotica 40:621–9
   PubMed Web of Science ®Google Scholar
• Uno Y, Fujino H, Iwasaki K, Utoh M. (2010a). Macaque CYP2C76 encodes cytochrome P450 enzyme not orthologous to any human isozymes. Curr Drug Metab 11:142–52
   PubMed Web of Science ®Google Scholar
• Uno Y, Uehara S, Kohara S, et al. (2010b). Cynomolgus monkey CYP2D44 newly identified in liver, metabolizes bufuralol and dextromethorphan. Drug Metab Dispos 38:1486–92
   PubMed Web of Science ®Google Scholar
• Uno Y, Fujino H, Kito G, et al. (2006). CYP2C76, a novel cytochrome P450 in cynomolgus monkey, is a major CYP2C in liver, metabolizing tolbutamide and testosterone. Mol Pharmacol 70:477–86
   PubMed Web of Science ®Google Scholar
• Uno Y, Hosaka S, Matsuno K, et al. (2007). Characterization of cynomolgus monkey cytochrome P450 (CYP) cDNAs: is CYP2C76 the only monkey-specific CYP gene responsible for species differences in drug metabolism? Arch Biochem Biophys 466:98–105
   PubMed Web of Science ®Google Scholar
• Uno Y, Iwasaki K, Yamazaki H, Nelson DR. (2011a). Macaque cytochromes P450: nomenclature, transcript, gene, genomic structure, and function. Drug Metab Rev 43:346–61
   PubMed Web of Science ®Google Scholar
• Uno Y, Uehara S, Murayama N, Yamazaki H. (2011b). CYP1D1, pseudogenized in human, is expressed and encodes a functional drug-metabolizing enzyme in cynomolgus monkey. Biochem Pharmacol 81:442–50
   PubMed Web of Science ®Google Scholar
• Wang MZ, Wu JQ, Bridges AS, et al. (2007). Human enteric microsomal CYP4F enzymes O-demethylate the antiparasitic prodrug pafuramidine. Drug Metab Dispos 35:2067–75
   PubMed Web of Science ®Google Scholar
• Wilkinson GR. (2005). Drug metabolism and variability among patients in drug response. N Engl J Med 352:2211–21
   PubMed Web of Science ®Google Scholar